Managing Diabetes - Q2 2022 by Mediaplanet UK&IE

Q2 2022 | A promotional supplement distributed on behalf of Mediaplanet, which takes sole responsibility for its content

READ MORE AT HEALTHAWARENESS.CO.UK

A PROMOTIONAL SUPPLEMENT DISTRIBUTED ON BEHALF OF MEDIAPLANET, WHICH TAKES SOLE RESPONSIBILITY FOR ITS CONTENTS

A targeted campaign has reduced blindness risk in South Asians Researchers show that vision loss due to diabetes can be largely prevented with culturally and linguistically appropriate information.

M INTERVIEW WITH Shahina Pardhan Director of Vision and Eye Research Institute, Anglia Ruskin University

WRITTEN BY Linda Whitney

Paid for by Anglia Ruskin University

any people with diabetes know that blindness is a major risk of uncontrolled diabetes. People of Asian and Black ethnicities, older people and those who have had diabetes for a long time, have an even higher risk. It’s tempting to assume that the higher risk for South Asian and Black people is genetic in origin, but now we know it’s not necessarily the case. Professor Shahina Pardhan, from the Vision and Eye Research Institute at Anglia Ruskin University says: “Our research shows that sight-threatening retinopathy is higher in South Asians, even when age and duration of diabetes are taken into account. We have shown that the high risk in South Asians and Black people is less genetic in nature and more to do with lifestyles. Once we knew this, we decided to research the causes and take action to tackle them.” For people with diabetes, it is important that good diabetic control is maintained in order to reduce the risk of complications such as blindness. Regular retinal screening is also vital as it will reduce the risk of blindness by 60-90%. Barriers preventing actions Professor Pardhan explains: “We found that people of South Asian origin reported a number of barriers that influenced their capacity to maintain good diabetic control. These included lower awareness of the fact that uncontrolled diabetes increases the risk of blindness, as well as lower literacy around physical activity and diet.”

Very few patients who were at higher risk of diabeticrelated blindness had attended the existing diabetic training programmes, citing language barriers and the fact that they were not culturally appropriate. Other barriers included a lack of awareness that diabetes could still be affecting the eyes despite good vision, as well as the idea that attending retinal screening appointments would lead to having to buy new spectacles. “This suggests that the current diabetes training programmes are not ‘fit for purpose’ for everyone,“ says Professor Pardhan. Creating a more accessible campaign Professor Pardhan decided to launch a campaign programme to tackle the issue. She says: “We have worked with multi-disciplinary teams to develop linguistically appropriate video-based training programmes delivered in Urdu, Nepali and Hindi. Using community champions, these have been delivered at grassroot levels in mosques, community centres, temples and on radio and TV programmes in the UK and overseas. It is also used in hospitals on newly diagnosed people with diabetes.” “To date they have helped over 125,000 people globally, by improving health literacy and changing behaviour, including improved uptake of retinal screening. Health literacy using culturally-appropriate training helps to reduce the risk of blindness due to diabetes.”

Scan the QR code to find out more

A needle-free CGM system is set to change type 2 diabetes care A new CGM system can help train users to keep their blood glucose levels within healthy ranges without the use of a needle.

N INTERVIEW WITH Jenny Wilkinson Diabetes Specialist Nurse (BA Hons RGN, Dip Diabetes), MySugarWatch WRITTEN BY Linda Whitney

eedles are a part of the daily routines of a person living with diabetes, for checking blood glucose levels in type 2 diabetes, their continuous use can be challenging for many. Whilst continuous glucose monitors (CGM) do not replace use of needles, they have proved beneficial in monitoring blood glucose levels more regularly. Now, in the latest of new technology advancements, a new CGM is set to launch which involves no needles.

to see the effects of their lifestyle and diet on their blood glucose levels.

Creating trending blood patterns Jenny says: “It uses a patented skin patch sensor that measures your glucose levels via the interstitial fluid that surrounds the cells. Currently, users will calibrate the system by making one fingerpick test a day, but this is far less than would be necessary The aim is to educate using non-continuous monitoring.

members so that they can Skin patch to monitor glucose levels “MySugarWatch (MSW) is a needle-free Education around healthy ranges easily keep within their ideal daily disposable skin patch that links to The aim is to educate members so that blood glucose range and can your mobile phone and monitors your they can easily keep within their ideal quickly spot the high spiky glucose levels every five minutes,” says blood glucose range and can quickly spot patterns of blood glucose Jenny Wilkinson, one of the diabetes the high spiky patterns of blood glucose specialist nurses working with MSW. “It’s levels that can be dangerous. levels that can be dangerous. the only CGM that is needle-free.” MSW believes that using the CGM The package, which includes the monitor for three to four days a month device, the app that allows you to view your blood can be enough to help people to reverse the effects of sugar levels, plus access to video coaches who will give type 2 diabetes and pre-diabetes as well as help high-risk individual advice about diet and lifestyle, is set for launch individuals reduce their chances of developing late this autumn. It is aimed at people with type 2 diabetes the condition. (T2D), people with pre-diabetes and anyone who wants

READ MORE AT HEALTHAWARENESS.CO.UK

Paid for by MySugarWatch

Find out more at mysugarwatch.je

MEDIAPLANET

A PROMOTIONAL SUPPLEMENT DISTRIBUTED ON BEHALF OF MEDIAPLANET, WHICH TAKES SOLE RESPONSIBILITY FOR ITS CONTENTS

It’s no joke – getting the facts straight on type 1 diabetes The myths and misconceptions that underlie jokes around diabetes have a real impact on those living type 1.

I WRITTEN BY Kate Gerrard Senior Communications Officer, JDRF UK

won’t name names, but two statements were broadcast on national prime time TV: “That’s diabetes on a plate” and “I think I’ve just developed diabetes.” As a type 1 diabetes charity, our supporters have told us how upsetting and frustrating comments like these are and we’re sure it’s the same for people living with type 2. Our recent survey found that 35% of UK adults didn’t know the difference between type 1 and type 2 diabetes and, as the jokes above indicate, they are often lumped together. We also found that 35% of adults didn’t know that type 1 diabetes is a life-threatening condition and a fifth believed type 1 can be put into remission. Getting the facts straight Approximately 400,000 people live with type 1 in the UK. It is an autoimmune condition, caused by the immune system mistakenly attacking insulin-producing cells in the pancreas.

Someone living with type 1 diabetes has to inject insulin and monitor their blood glucose levels several times a day to stay healthy - and stay alive. Blood glucose levels dropping too low can result in unconsciousness, coma and even death. Blood glucose levels becoming too high can cause damage to blood vessels, nerves and organs, and cause a build-up of acid in the blood which eventually causes the body to poison itself. Searching for cures Myths and jokes diminish the reality of intensive daily type 1 diabetes management and the urgent need to find a cure. At JDRF, the leading global organisation funding type 1 diabetes research - where many of us live with type 1 or, like myself, are closely connected with someone who does our research is making headway. Research we have funded has found an immunotherapy that can delay the onset of type 1 in people at high risk

of developing the condition by three years, which may soon become the first licensed immunotherapy for type 1. Our research is also finding ways to create new insulin-producing beta cells in the lab. If these new cells can both be implanted and protected from further immune attack, we could be looking at a functional cure, freeing people living with type 1 from the daily burden of type 1 diabetes management. We’re moving closer to that moment, but until then we need to approach type 1 diabetes research with urgency and the people dealing with it with compassion and support, not jokes.

Free to stretch to your limits. Thanks to the FreeStyle Libre 2 system, you’re free to play as wildly as you like. Try it for free at Sample.FreeStyle.Abbott Images are for illustrative purposes only. Not actual patient or data. © 2022 Abbott. FreeStyle, Libre, and related brand marks are marks of Abbott. ADC-58849 v1.0 06/22.

MEDIAPLANET

READ MORE AT HEALTHAWARENESS.CO.UK

A PROMOTIONAL SUPPLEMENT DISTRIBUTED ON BEHALF OF MEDIAPLANET, WHICH TAKES SOLE RESPONSIBILITY FOR ITS CONTENTS

The importance of widening access to glucose monitoring technology Updated NICE guidelines aim to help people with diabetes get access to the right technology, resources and information and improve the management of their condition.

D INTERVIEW WITH Daniel Newman Type 1 diabetes advocate and host of The Talking Type 1 Podcast

WRITTEN BY Tony Greenway

aniel Newman knows all about the challenges of living with type 1 diabetes: he was diagnosed with diabetes when he was just 10 years old. Now, 25 years later, he serves as a patient representative on the committee that recently updated National Institute of Health and Care Excellence (NICE) guidelines regarding access to diabetes technology. Whenever national guidelines are reviewed or developed, it’s vital to listen to the patients’ point of view, he insists. “Someone who has lived experience of a health condition has real, day-to-day insight to offer,” says Daniel. “That’s my function on the committee. Nevertheless, it’s a big responsibility to be involved with a prestigious organisation such as NICE, representing a community of people living with type 1 diabetes.” The updated NICE guidelines recommend wider access to flash and continuous glucose monitoring (CGM) for people living with diabetes on the NHS. This technology — along with an insulin pump — has certainly revolutionised Daniel’s life. “I’d have been about 12 when I received my first glucose monitor,” he says. “Before that, I was still managing my diabetes with constant finger pricking and using test strips however now the process was quicker. The sensor I currently use is on the back of my upper arm which monitors my glucose levels. I can view my levels on my phone after scanning the sensor. The alarms on my sensor alert me when my levels are higher or lower than I’d like them to be.” Challenges in accessing the right diabetes technology Constant management of diabetes can be a weary and exhausting responsibility that either falls on those

READ MORE AT HEALTHAWARENESS.CO.UK

It’s a big responsibility to be involved with a prestigious organisation such as NICE, representing a community of people living with type 1 diabetes. individuals living with the condition or their parents and carers, says Daniel. But technology such as flash glucose monitoring — where glucose levels are checked with a simple scan of a sensor placed on the back of the upper arm — makes management easier. There are a number of barriers that still exist for those managing their diabetes. One being accessing this type of innovation, which isn’t always straightforward. Daniel points out that people from lower socioeconomic and/ or ethnic minority backgrounds, or those who don’t speak English as their first language, may face significant challenges in accessing diabetes tech. “If you don’t know what is available to you, or how to get it, you can be at a disadvantage,” he says. “I’m hopeful that as policies have changed, the disadvantages will be removed too.” Stigma is another challenge, admits Daniel. “There’s a blame culture around both types of diabetes — a feeling that a person somehow caused their own condition. That’s unfair. People need to better understand this condition, and also recognise that it isn’t just a physical condition. There is a mental and emotional aspect to it, which must also be taken into consideration.”

MEDIAPLANET

A PROMOTIONAL SUPPLEMENT DISTRIBUTED ON BEHALF OF MEDIAPLANET, WHICH TAKES SOLE RESPONSIBILITY FOR ITS CONTENTS

Experience freedom from Multiple Daily Injections Simplify diabetes management with the Omnipod DASH® System > Tubeless Insulin Pump > Personalised insulin delivery > Small and waterproof* Pod

Phoenix D.

controlled by a smartphone-like

PODDER ® SINCE 2018

device (Personal Diabetes Manager) > Simple and discreet way to deliver insulin Simplify LifeTM.

ORDER A FREE SAMPLE POD† Omnipod.com

Actual size of Pod

Always consult your Healthcare Provider for suitability. Insulet_UK

OmnipodUK

omnipoduk

*The Pod has a waterproof IP28 rating for up to 7.6 metres for up to 60 minutes. The PDM is not waterproof. †The sample Pod is a needle-free Pod that does not deliver insulin. PDM is not included. Screen image is an example, for illustrative purposes only. ©2022 Insulet Corporation. Omnipod, the Omnipod logo, DASH, the DASH logo, Simplify Life and Podder are trademarks or registered trademarks of Insulet Corporation in the USA and other various jurisdictions. All rights reserved. Glooko is a trademark of Glooko, Inc. and used with permission. All other trademarks are the property of their respective owners. The use of third party trademarks does not constitute an endorsement or imply a relationship or other affiliation. Insulet Netherlands BV Stadsplateau 7, 3521 AZ Utrecht, Pays-Bas. INS-ODS-10-2021-00019 V1 pt5

MEDIAPLANET

2022 PrintAds-Paed-ENG-INS-ODS-10-2021-00019 V1_265x330.indd 1

READ MORE AT HEALTHAWARENESS.CO.UK 07/06/2022 14:10

A PROMOTIONAL SUPPLEMENT DISTRIBUTED ON BEHALF OF MEDIAPLANET, WHICH TAKES SOLE RESPONSIBILITY FOR ITS CONTENTS

Type 1 diabetes from the perspective of an active 10-year-old

ADVERTORIAL

diagnosed type 1 diabetes — and it soon became clear that Skye’s DKA was extremely serious. “I asked a doctor if Skye was going to be OK and she didn’t give me a definite answer,” remembers Kelly. “She said: ‘This is a really dangerous situation and you’re very lucky to have got here when you did.’ If it had been five minutes later, Skye wouldn’t be here now.”

Paid for by Insulet

But management soon becomes second nature.

Image provided by Insulet

Skye, an adventurous 10-year-old Omnipod® user, shares her experience identifying the signs of type 1 diabetes. She started her diabetes management during the global pandemic and faced a diagnosis challenge.

INTERVIEW WITH Kelly Niblock and her daughter, Skye A paediatric Omnipod® user WRITTEN BY Tony Greenway

t can be easy to miss the signs and symptoms of diabetes. It’s even easier to miss them in the middle of a global pandemic, as Kelly Niblock and her daughter, Skye, know only too well. In fact, Skye became so poorly with undiagnosed type 1 diabetes that she developed severe diabetic ketoacidosis (DKA), a serious complication of the disease, which resulted in her being rushed to hospital. Skye had been a bubbly, sportsloving 10-year-old. But in 2020, just as COVID-19 appeared and lockdowns and home-schooling began, she started to feel unwell. “The trouble was so many things were happening at the same time,” says Kelly. “Rather than being her usual active self, Skye became tired and would lay around watching television. That wasn’t like her. She also became anxious about everything — but I thought she was feeling isolated and depressed because of the pandemic.”

READ MORE AT HEALTHAWARENESS.CO.UK

The tell-tale signs of type 1 diabetes that can be overlooked When lockdown restrictions relaxed, Kelly tried to gee Skye up by taking her and her brothers out for walks. On one of these occasions, she noticed that Skye was constantly gulping down water. “Again, it was the hottest day of the year,” says Kelly. “So although the signs and symptoms were there, there was always another reason for them.” It wasn’t until the week before Skye’s diagnosis in July 2020 that symptoms began to manifest more alarmingly. Skye started to complain of a headache and she needed to go to the toilet more frequently. “Then Skye complained that she couldn’t breathe properly, and we wondered if it was COVID-19,” says Kelly. “I said we should go to the hospital, but she said: ‘No, I think I’m all right.’” But later that night Skye began to projectile vomit, so Kelly immediately phoned 111, described Skye’s symptoms and was told that an ambulance was on its way. At the hospital, doctors immediately

Managing diabetes with modern technology Thankfully, Skye’s condition stabilised and she was told about type 1 diabetes. “I only knew about type 2,” says Skye, who is feeling like her old self again and approaching her 12th birthday. “So at first I was confused, then I got scared.” Initially, Skye had to get to grips with a new regime of healthcare, which involved constant finger pricking and injecting insulin regularly, which she often found inconvenient and uncomfortable. However, she now manages her condition with some diabetes technology; a tubeless and wireless insulin pump called the Omnipod DASH® Insulin Management System. She showed me her Pod, which she was wearing discreetly under her upper arm.* Skye programmes the PDM (Personal Diabetes Manager) to deliver the insulin she needs in precise doses via the Pod. Apart from being more convenient, it means she rarely has to inject. Skye is now living life to the full again. “Type 1 diabetes hasn’t stopped me from doing anything I want to do,” she says. Skye’s favourite hobbies are all possible, helped by her Omnipod DASH® System and her healthcare team. “I’ve figured out a way to do sports and everything I loved before.” Kelly’s message for parents is that a diabetes diagnosis is daunting and overwhelming at first. “But management soon becomes second nature,” she says. “I made a promise to Skye that she would have the same life as everyone else. Diabetes can be a challenge, but it never stops us from having adventures.” *The pod has many approved sites on the body and site rotation is recommended.

Scan the QR code to find out more

MEDIAPLANET

A PROMOTIONAL SUPPLEMENT DISTRIBUTED ON BEHALF OF MEDIAPLANET, WHICH TAKES SOLE RESPONSIBILITY FOR ITS CONTENTS

Helping people live their best lives through an online diabetes community Two girls share their experiences of living with their diabetes and how their online presence has helped to connect people living with diabetes. Q: When were you diagnosed with diabetes and how did you and your friends/family react?

WRITTEN BY Ellen Watson Social media content creator, Diabetes UK supporter

WRITTEN BY Beth McDaniel Social media content creator, Diabetes UK supporter

Ellen - I was diagnosed with type 1 diabetes the week before I turned seven, so it wasn’t the best birthday present. I was very young but my mother is a nurse, so she fortunately noticed the symptoms I had (extreme thirst and irritability) and took me to the doctors. Due to my age, my family were devastated by the news as they feared my life could be very challenging. Beth - I have a very different diagnosis story from Ellen as I was diagnosed at 20 years old. This was a huge shock for me as I was just entering my adult life when I received this diagnosis due to a temporary loss in vision. My family and friends have been so supportive and have made this journey so much easier. Q: Once you were diagnosed, how quickly did you start sharing your diabetes journey online? We both only began to share our diabetes journey together in October 2019 on TikTok, when it was an extremely new platform. We recorded a ‘night out’ transformation video, not related to our diabetes, which blew up due to our CGM (continuous glucose monitor) devices on our arms. After the positive reaction, we decided to roll with it and

that is how The Diabetic Duo was created. Since then we create fun, light-hearted, big sister advice-style videos for people with diabetes and their friends and families. Q: What have you found out about the diabetes community since teaming up online? We never realised how huge the online diabetes community was until we began The Diabetic Duo. It is amazing to see how many people with diabetes are proudly living their lives online which we know massively helps others who are maybe struggling. We have both met amazing charities and organisations like Diabetes UK who provide amazing support and care for other people with diabetes. Q: How do you hope to inspire others living with diabetes in the future? We hope we can inspire other people with diabetes to live their best lives! Diabetes does not hold you back from your dreams. Yes, you do have to be more organised and make hundreds of extra decisions a day all while looking after your diabetes, but as long as you keep a positive attitude, nothing can stop you.

Beth McDaniel and Ellen Watson post on social media as The Diabetic Duo and are Diabetes UK supporters.

Educate today to protect tomorrow One in nine adults will be living with diabetes by 2030. Healthcare professionals and people affected must be equipped with the knowledge to understand and manage the condition.

D WRITTEN BY Professor Andrew Boulton President, International Diabetes Federation

iabetes represents a significant challenge to global health and development. It is responsible for almost seven million deaths per year, according to latest figures from the International Diabetes Federation (IDF). Evidence indicates that the number of people affected globally has passed the half a billion mark (537 million) and shows no sign of declining, with the number expected to exceed 640 million by 2030. Unsurprisingly, healthcare systems are struggling to keep up with these growing numbers. During the pandemic, many people with diabetes have missed appointments and lost out on opportunities to check for complications or adjust treatment regimes. In the UK alone, one in six people with diabetes have not had contact with a healthcare professional since the start of the pandemic.

need to optimise the time they spend with patients. People living with diabetes need to ensure best self-care practices. Both need access to the best possible training and education. Building capacity to provide care Primary care providers are at the heart of the diabetes response. They need the knowledge, time and tools to not only detect diabetes and refer those concerned to a specialist, but also help those in their care manage their condition and navigate the healthcare system. They must also be able to provide the best available care, at the earliest opportunity, to delay or prevent diabetes complications.

In the UK alone, one in six people with diabetes have not had contact with a healthcare professional since the start of the pandemic.

The majority of diabetes care is self-care Diabetes is a complex, lifelong condition that demands multiple and frequent decisions about such things as food choices, physical activity, monitoring blood sugar levels and taking medication. Furthermore, diabetes can change over the course of life and need significant adjustments. However, people with diabetes spend less than three hours per year with a healthcare professional. This means they self-manage their condition more than 99.9% of the time. With consultation time so limited, healthcare professionals 08

MEDIAPLANET

Providing ongoing diabetes education Now, more than ever, primary healthcare providers need access to ongoing training to provide the best possible care for people with diabetes. People living with diabetes require reliable, easy-toacquire information to support their self-care. We need to educate today to

protect tomorrow. IDF is committed to facilitating ongoing education for healthcare professionals and people living with diabetes. Free educational resources are available to support training for healthcare professionals and to help people with diabetes understand their condition.

Find out more at idfdiabeteschool.org understanding diabetes.org

READ MORE AT HEALTHAWARENESS.CO.UK

A PROMOTIONAL SUPPLEMENT DISTRIBUTED ON BEHALF OF MEDIAPLANET, WHICH TAKES SOLE RESPONSIBILITY FOR ITS CONTENTS

Chronic kidney disease associated with type 2 diabetes: testing could help save lives Chronic kidney disease is a common complication of type 2 diabetes, yet many patients and healthcare practitioners do not understand it.

T INTERVIEW WITH Dr Patrick Holmes General Practitioner Partner, Primary Care Diabetes Society

WRITTEN BY Linda Whitney

here are now around 4.4 million people with type 2 diabetes (T2D) in the UK, including an estimated 1 million who are undiagnosed. About one in ten of the over 40s have it – and yet, there is still widespread misunderstanding of the disease’s complications. “Many people, including some healthcare practitioners, don’t fully appreciate the complications that T2D often leads to,” says Dr Patrick Holmes, a GP who also works alongside the Primary Care Diabetes Society. He explains: “Diabetes is a serious condition where the blood glucose level of the body is too high. Over a long period, high glucose levels can lead to complications, including serious damage to the heart, eyes, feet and kidneys.” Chronic kidney disease “Chronic kidney disease (CKD) is already the leading cause of kidney failure in the UK and the leading cause of death among people with T2D,“ says Dr Holmes. Up to 40% of people with T2D could eventually develop CKD, which reduces kidney performance. This can increase the risk of cardiovascular events, such as heart attacks and strokes. Most CKD symptoms do not appear until it is well-advanced and the rate of death from heart attacks and strokes increases as it progresses. People with T2D who develop CKD early in life can lose up to 16 years of their potential lifespan.

We need more healthcare practitioners and patients to understand the importance of having both tests. Together they can detect CKD and tell us how quickly it will progress.

Paid for by BAYER

This article was developed and sponsored by Bayer. PP-KER-GB-0151 / June 2022

Early detection of CKD associated with T2D is key There are ways to manage the progress of CKD, including eating healthily, staying fit and controlling blood pressure and blood sugar, plus cholesterol-reducing treatments. But management is more effective if started early. Importance of testing For CKD associated with T2D, guidelines recommend using two main tests (eGFR and UACR) together to determine how well the kidneys are functioning and the level of damage (i.e., how much protein is leaking into the urine). The eGFR (estimated glomerular filtration rate) is measured by a blood test, typically given to patients annually, while the UACR (urine

READ MORE AT HEALTHAWARENESS.CO.UK

albumin-to-creatinine ratio) requires a urine test, typically administered to only about 60% of patients each year. The two tests should be repeated after three months. Dr Holmes says: “The shortfall in people with T2D taking the urine test is an issue, because it spots the development of CKD earlier than the blood test. By the time the blood test identifies CKD, about half the potential damage to the kidneys is done – and it cannot be reversed. “We need more healthcare practitioners and patients to understand the importance of having both tests. Together they can detect CKD and tell us how quickly it will progress. Patients should ask about the tests and ensure they are repeated.” Next steps In the past GPs used to refer patients for dialysis once kidney function had dropped to 25% normal capacity, but a new tool called the Kidney Failure Risk Equation (KFRE), used in primary care can help predict which patients need hospital care. It takes into account a patient’s age, gender and the results of the urine and blood tests. Dr Holmes urges patients to ask about it. A new website that allows patients and healthcare practitioners online access to the KFRE is now open. It’s aimed mainly at people with kidney function below 50% who already know the results of their blood and urine tests, but it can be accessed by anyone. “It tells you your risk of kidney failure in the next two to five years and whether a referral to a kidney specialist should be considered,” says Dr Holmes. Saving lives, money – and cut carbon footprint Understanding how to recognise and delay CKD progression in people with T2D can save lives, save money for the NHS from dialysis or transplants, and contribute to the NHS’s carbon net zero goal. “About 80% of the cost of type 2 diabetes to the NHS comes from dealing with complications – CKD is one of the costliest,” says Dr Holmes. “Greater awareness of CKD in type 2 diabetes benefits everyone.”

Find out more at bayer.co.uk

MEDIAPLANET

A PROMOTIONAL SUPPLEMENT DISTRIBUTED ON BEHALF OF MEDIAPLANET, WHICH TAKES SOLE RESPONSIBILITY FOR ITS CONTENTS

Harnessing innovation with life changing potential One hundred years on from the first patient receiving insulin injections, scientists’ continued research is helping people with diabetes better manage their condition, reducing the burden of existing treatments and improving quality of life.

iabetes has reached pandemic levels, with 537 million people living with diabetes worldwide. In the UK, 4.9 million people have diabetes, predicted to reach 5.5 million by 2030. The daily challenge for anyone with diabetes is to maintain their blood glucose within a healthy target range. Even with gold standard insulins available today, there remains a need for faster acting insulins to counteract the swift rise in blood sugar that happens at mealtimes. This is important as time outside of the healthy target range leads to the serious disease complications associated with diabetes that bring long-term morbidity and healthcare costs. The NHS spends at least £10 billion a year – about 10% of its entire budget – on diabetes, with almost 80% of it treating serious complications. Driven by the obesity epidemic, a growing number of people with diabetes are becoming insulin resistant and to manage their blood glucose will often need multiple types of insulin and to inject large volumes more often, which is a heavy daily burden. New treatment options At Arecor Therapeutics, our scientists are developing faster acting and concentrated insulins to enable a new frontier in diabetes management. These offer the potential to better control blood glucose and can be used in ultra-concentrated formulations, enabling reduced injection volumes, fewer injections per day and the next generation of miniaturised insulin pumps. Our faster acting insulins may also facilitate a fully closed loop artificial pancreas, a potentially life changing approach to living with diabetes. The NHS is conducting a 900-patient trial of this technology using a sensor to continually monitor blood sugar, and a pump to automatically adjust and deliver the insulin required. Ultra-rapid acting insulins will be a critical enabler to their success. Once considered science fiction, technology now plays an increasing part in healthcare. Perhaps, 100 years on from that first insulin injection, artificial pancreas systems are no longer the unattainable Holy Grail of diabetes management.

WRITTEN BY

Sarah Howell Chief Executive Officer, Arecor

Paid for by Arecor Find out more at arecor.com

MEDIAPLANET

Greater awareness is needed of diabetes mental health impact Type 1 diabetes is a life-long health condition, requiring continual selfmanagement. The result of which can have a significant impact on peoples physical and mental wellbeing.

ype 1 diabetes occurs when the pancreas can no longer produce the hormone insulin. People living with type 1 diabetes require lifelong treatment with insulin either in the form of multiple injections per day or an insulin pump. Calculating insulin levels Each time the person eats they must calculate how much insulin to take. Too much insulin can result in a very low blood glucose level which can result in coma or death and too little insulin can result in a high blood glucose level and acid accumulating in the blood which is a medical emergency. These calculations must consider the carbohydrate content of the food to be eaten but also many other factors including exercise, stress and illness. It is important that blood glucose levels are kept within a strict range to prevent or delay the onset of diabetes related complications that include heart attacks, strokes, blindness and kidney failure. This continual self-management is very complex and psychologically demanding for individuals. Impact on mental health People living with diabetes are more likely to experience mental health disorders, such as depression, stress, anxiety and diabetes distress. On top of this, the combination of diabetes and mental health disorders tend to lead to worse outcomes for both conditions. For example, quality of life is worse, diabetes self-management is impaired, complications are increased and life expectancy is reduced. It is important to note that there is a low detection rate of mental health disorders in people with diabetes, nearly half of the cases go undetected. Because of this, people who have been diagnosed with diabetes may feel shame and stigma towards them. It is crucial that we address the link between diabetes and mental health.

People living with diabetes are more likely to experience mental health disorders, such as depression, stress, anxiety and diabetes distress. Reducing stigma and barriers To improve the mental and physical health of people with diabetes, it has been recommended that people with diabetes receive regular mental health screening and support to treat mental health disorders. However, integrated care of both diabetes and mental health disorders remains poor. We must increase our understanding of how many people and what type of mental health disorders are being experienced by people with diabetes. This will help to improve health outcomes and care for these people.

WRITTEN BY Dr Hermione Price Consultant Diabetologist, Southern Health NHS Foundation Trust

WRITTEN BY Jeni Baykoca Clinical Trials Assistant, Southern Health NHS Foundation Trust

READ MORE AT HEALTHAWARENESS.CO.UK

A PROMOTIONAL SUPPLEMENT DISTRIBUTED ON BEHALF OF MEDIAPLANET, WHICH TAKES SOLE RESPONSIBILITY FOR ITS CONTENTS

Low calorie diets can contribute to diabetes remission

Paid for by exante

Images provided by exante | Christine’s before and after photos.

According to recent research, following a low calorie diet through meal replacements can contribute to sending type 2 diabetes into remission.

T WRITTEN BY Lujain Alhassan Nutritionist / Nutrition Coordinator, exante

he ‘Diabetes Remission Clinical Trial’ (DiRECT study) has been investigating the impact of low-calorie diets on those living with type 2 diabetes. The latest findings have shown that over a third of people who took part are in remission two years after. Early results from another recent trial also show that remission may be possible for people with a BMI of 27 or less. Potential benefits of low-calorie diets Low calorie diets are designed to result in significant weight loss. This is because they help to reduce the levels of visceral fat (fat surrounding the liver, pancreas and other organs), which may improve pancreatic

function and the production of insulin. Excessive amounts of visceral fat are associated with insulin resistance, so following a low-calorie diet may also prevent diabetes. exante offer simple and convenient diet plans designed to help people reach their goals quickly, safely and effectively. With 27 vitamins and minerals in each meal replacement, the range is a perfect, nutritious option for weight loss, maintenance or even just a convenient meal on-the-go. The wide range of bars, shakes, meals and even soups contain a third of our nutrient reference values and are packed with protein and fibre.

Making personalised care and support work for people with type 2 diabetes

P Paid for by Healum

READ MORE AT HEALTHAWARENESS.CO.UK

Managing weight loss and diabetes Christine explains how the 800 plan helped her lose weight: “Before I started exante, I was around 21 stone 13 lbs. I suffered with type 2 diabetes and high blood pressure which needed to be managed with a lot of medication. “I knew I had lots of weight to lose before my diabetes worsened, I opted for the 800-calorie plan; with this plan I used three meal replacement products a day alongside a 200 calorie healthy meal or snack. “Since finding the plan, I’ve lost over 10 stone and now weigh 11 stone 7lbs. I can’t describe how much of an impact it has had on my life; I’m so much more confident and happier in myself and I’m off all my medication. Better yet, I managed to put my type 2 diabetes into remission, something I never imagined could happen.” exante always recommends talking to a doctor or medical professional before using their products and plans to help you lose weight. If you have, or are worried you may have diabetes please consult your GP.s

12 GP surgeries who were trained to use the Healum app and care-planning software. The project has so far been a great success, with clear benefits for both patients and clinicians. “A key challenge in diabetes management is to motivate and support individuals with diabetes to make healthy choices, positive lifestyle decisions and to understand how to best manage their diabetes in a way that means something to them,” says Dr Adrian Heald, Consultant Diabetologist at Salford Royal and Chief Investigator of the study in Eastern Cheshire.

Personalised plans of care and support, created as part of a shared decision-making process with healthcare professionals have been shown to improve outcomes and empower people with type 2 diabetes in a recently published innovative new study. roactive personalised care is about enabling people to understand the set of health choices that are available to them and empowering them to make those choices. This is true whether we are talking about medication, medical services, community-based services, healthy food options or lifestyle choices. The NHS Long Term Plan’s ambition is to make personalised care and support planning ‘business as usual’. There are however significant financial, organisational and time barriers amongst disparate teams of healthcare professionals, to provide joined-up care, support and education to people living with type 2 diabetes.

Excessive amounts of visceral fat are associated with insulin resistance, so following a low-calorie diet may also prevent diabetes.

The role of technology Well-designed care and support planning software can enable healthcare professionals working across primary, secondary and community settings to create digital plans of care in partnership with patients who are living with type 2 diabetes that can be accessed at any time through a mobile app. This is a convenient and secure way for patients to track and monitor their health and to access support, education and advice from their GP surgery to manage their diabetes. Evaluating the benefits A study was funded by Innovate UK and supported by the NIHR involving 250 people with type 2 diabetes across

Health outcomes so far The preliminary results of an 18-month trial presented at the Diabetes UK Annual Professional Conference in March 2022 showed that people who used it had an average 9.5% reduction in the HbA1c blood glucose average control measure compared with a 2% reduction in the comparable control group. These promising outcomes bode well for the future, as more people living with type 2 diabetes find the path to a healthier future. Healum has just launched a research network with the aim of providing people living with type 2 diabetes choice and control over how they share their health information with healthcare professionals and researchers who are seeking to improve personalised care.

Find out more at exantediet.com

WRITTEN BY Jonathan Abraham Chief Executive Officer, Healum

WRITTEN BY Dr Adrian Heald Consultant Diabetologist Salford Royal Hospital

To register your interest visit healum.com/ research

MEDIAPLANET

A PROMOTIONAL SUPPLEMENT DISTRIBUTED ON BEHALF OF MEDIAPLANET, WHICH TAKES SOLE RESPONSIBILITY FOR ITS CONTENTS

MEDIAPLANET

READ MORE AT HEALTHAWARENESS.CO.UK